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Abstract
The parasympathetic nervous system is important for b-cell secretion and mass regulation. Here, we characterized
involvement of the vagus nerve in pancreatic b-cell morphofunctional regulation and body nutrient homeostasis in 90-day-old
monosodium glutamate (MSG)-obese rats. Male newborn Wistar rats received MSG (4 g/kg body weight) or saline [control
(CTL) group] during the first 5 days of life. At 30 days of age, both groups of rats were submitted to sham-surgery (CTL and
MSG groups) or subdiaphragmatic vagotomy (Cvag and Mvag groups). The 90-day-old MSG rats presented obesity,
hyperinsulinemia, insulin resistance, and hypertriglyceridemia. Their pancreatic islets hypersecreted insulin in response to
glucose but did not increase insulin release upon carbachol (Cch) stimulus, despite a higher intracellular Ca2+ mobilization.
Furthermore, while the pancreas weight was 34% lower in MSG rats, no alteration in islet and b-cell mass was observed.
However, in the MSG pancreas, increases of 51% and 55% were observed in the total islet and b-cell area/pancreas section,
respectively. Also, the b-cell number per b-cell area was 19% higher in MSG rat pancreas than in CTL pancreas. Vagotomy
prevented obesity, reducing 25% of body fat stores and ameliorated glucose homeostasis in Mvag rats. Mvag islets
demonstrated partially reduced insulin secretion in response to 11.1 mM glucose and presented normalization of Cch-induced
Ca2+ mobilization and insulin release. All morphometric parameters were similar among Mvag and CTL rat pancreases.
Therefore, the higher insulin release in MSG rats was associated with greater b-cell/islet numbers and not due to hypertrophy.
Vagotomy improved whole body nutrient homeostasis and endocrine pancreatic morphofunction in Mvag rats.
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Introduction
Central and peripheral mechanisms are involved in the
regulation of body glucose homeostasis (1). Insulin and glu-
cagon secretion are directly controlled by peripheral glucose
levels and by the central nervous system (CNS) through
the autonomic nervous system (ANS) (2). Pancreatic islets
are innervated by vagal cholinergic nerves and sympathetic
fibers (3). The parasympathetic nervous system (PNS)
potentiates insulin secretion by the acetylcholine muscarinic
3 (M3) receptor, which activates phospholipase C (PLC)
that, in turn, produces the intracellular messengers inositol-
1,4,5-triphosphate (IP3) and diacylglycerol (DAG) (2). In
contrast, the sympathetic nervous system (SNS), which
releases norepinephrine, predominantly decreases insulin
secretion via the a2-adrenergic receptors (3).
Nutrients and hormones also contribute to pancreatic
b-cell mass steady state, and the PNS has been found to
be involved in b-cell mass regulation under normal and
pathological conditions (4-9).While themechanism of action
of the PNS upon endocrine pancreatic mass regulation is
not completely understood, there is some evidence to
demonstrate that, in obesity, increased vagal action may
lead to a vicious cycle that increases fat storage and disrupts
body energy homeostasis (10,11).
Early postnatal administration of monosodium gluta-
mate (MSG) in rodents produces neuronal necrosis in the
arcuate nuclei of the hypothalamus and median eminence,
which leads to development of obesity during adulthood
(12). MSG-induced obesity is characterized by hypo- or
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normophagy (13), higher fat deposition, glucose intoler-
ance, hyperinsulinemia, and insulin resistance (14).
Furthermore, pancreatic islets from MSG-obese rodents
secrete more insulin in response to glucose (15-17) but
present a diminished secretory function in response to
cholinergic stimulus (15,18). This effect is partly associated
with an alteration in ANS action, with a reduction in
sympathetic function, but enhanced PNS activity (10). We
previously demonstrated that subdiaphragmatic vagotomy
in MSG rats prevented obesity, glucose intolerance, and
pancreatic islet hypersecretion in response to glucose
(14,16), supporting the hypothesis that PNS action is
involved in pancreatic islet hyperfunction and related
comorbidities in MSG rodents. However, the mechanism
of action involved in such a process is unknown. Here, once
again using subdiaphragmatic vagal denervation, performed
at 30 days of age, we investigated whether the vagus nerve
is involved in endocrine pancreatic morphofunctional
alterations that lead to hyperinsulinemia and body nutrient
homeostasis disruption in 90-day-old MSG-obese rats.
Material and Methods
Induction of experimental obesity in rats
All experiments were approved by the Universidade
Estadual do Oeste do Parana´ (UNIOESTE) Committee
on Ethics in Animal Experimentation (Certificate #00812).
Male newbornWistar rats received a subcutaneous injection
of MSG [4 g/kg body weight (BW); MSG group], or saline
(1.25 g/kg BW; CTL group) during the first 5 days of life.
Pups were weaned on the 21st day of life and had free
access to standard rodent chow (Biobase, Brazil) and water.
The rats were housed in standard cages and maintained on
a 12:12-h light-dark cycle (lights on from 6:00 a.m. to 6:00
p.m.) under controlled temperature (22±16C).
Vagotomy
At 30 days of age, MSG and CTL rats, after 12 h of
fasting, were anesthetized with a mixture of 90 mg/kg
ip ketamine (Vetbrands, Brazil) and 9 mg/kg ip xylazine
(Vetbrands). Half of the rats were submitted to subdia-
phragmatic truncal vagotomy. The stomach and esopha-
gus were exteriorized from the peritoneal cavity and
humidified with saline. The common hepatic branch of
the ventral vagal trunk, the accessory celiac and gastric
branches of the ventral vagal trunk, and the dorsal vagal
trunk were cut (denoted as Mvag and Cvag groups) (19). In
sham-vagotomized rats (denoted as MSG and CTL
groups), the vagus nerve was separated from the
esophagus, but was not cut. At the end of the experimental
period (2 months later), stomach food retention from each
group was evaluated by the stomach weight per BW ratio to
confirm subdiaphragmatic vagal denervation (5,14).
Obesity and general nutritional parameters
Body weight and food intake were measured during
the experimental period (from the 30th to 90th day of life).
Food intake is reported as feed efficiency (food intake/BW
gain). At 90 days of age, both rat groups, after 12 h of
fasting, were weighed, and the nasoanal length was
measured to calculate the Lee index. Rats were then killed
by decapitation, and the retroperitoneal and perigonadal fat
pads were removed and weighed. Blood was collected and
serum was stored at –206C for insulin measurement by
radioimmunoassay (RIA). Total cholesterol (CHOL) and
triglycerides (TG) weremeasured using standard commercial
kits, according to the manufacturers’ instructions (Merck,
Germany; and Boehringer, Germany, respectively).
Intraperitoneal glucose tolerance test (ipGTT)
At the end of the experimental period, rats from all
groups were deprived of food for 8 h, and glycemia (time 0)
was measured using a glucose analyzer (Abbott, Optium
Xceed, USA). Subsequently, the rats received an ip injection
of 2 g/kg BW glucose, and blood samples were collected
at 15, 30, 60 and 120 min. Additional blood samples were
collected at 0 and 30 min of the test for insulin measurement
by RIA.
Body insulin sensitivity
Tissue insulin sensitivity was also evaluated using the
homeostasis model assessment (HOMA) index of insulin
resistance [(HOMA-IR)= fasting insulin (1 U/mL)6fasting
glucose (mM)/22.5]. For glucose disappearance rate (KITT)
evaluation, fasted rats were injected ip with 1 U/kg BW of
human insulin (Humulin R, Lilly, USA). Blood was taken
before insulin injection (time 0) and after 4, 8, 12, 16 and
20 min for glucose analysis. The KITT was calculated as
0.693/t1/2.
Lipids, TG, and CHOL content in the liver
Liver lipids were extracted by Folch’s method. The ex-
tract was evaporated and weighed by a gravimetric method
for total fat content measurement. Lipids were then diluted in
isopropanol for determination of the TG and CHOL content
in the liver using enzymatic colorimetric methods, according
to the manufacturer’s instructions (Laborclin, Bioliquid,
Brazil).
Islet isolation, static insulin secretion, and total islet
insulin content
Islets were isolated by collagenase (Sigma-Aldrich
Chemicals, USA) digestion of the exocrine pancreas and
then selection under a microscope to exclude any contam-
inating tissues. For static incubations, groups of four islets
were preincubated for 30 min at 376C with 0.5 mL Krebs-
bicarbonate (KBR) buffer with the following composition:
115 mM NaCl, 5 mM KCl, 2.56 mM CaCl2, 1 mM MgCl2,
10 mM NaHCO3, 15 mM HEPES, supplemented with
5.6 mM glucose, 3 g bovine serum albumin (BSA) per liter,
and equilibrated with a mixture of 95% O2-5% CO2 to
provide pH 7.4. This medium was then replaced with fresh
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buffer (1 mL), and the islets were incubated for 1 h with 2.8,
11.1 or 16.7 mM glucose. In another series of experiments,
islets were incubated with 11.1 mM glucose without or with
100 mM carbachol (Cch). At the end of the incubation
period, the supernatants were collected and maintained at
–206C. For islet insulin content, groups of four islets were
collected and transferred to tubes containing 1 mL deio-
nized water, and the islet cells were homogenized using a
sonicator (Brinkmann Instruments, USA). The insulin was
measured by RIA using human insulin radiolabelled with
125I as tracer, rat insulin as standard (Crystal Chem Inc.,
USA), and rat insulin antibody (donated by Dr Leclerq-
Meyer, FreeUniversity of Brussels, Belgium). The charcoal-
dextran method was used to separate free insulin from
antibody-bound 125I insulin (20).
Cytoplasmic Ca2+ oscillations
Fresh pancreatic islets were incubated with 5 mM fura-2
acetoxymethyl ester for 1 h at 376C in KBR buffer sup-
plemented with 5.6 mM glucose, 3 g BSA/L, at pH 7.4. The
islets were then washed with the same medium and were
placed in a chamber that was thermostatically regulated at
376C on the stage of an inverted epifluorescence mic-
roscope (Nikon Eclipse TE200, Japan). Islets were then
perifused with albumin-free KBR buffer containing 2.8 or
16.7 mM glucose, which was continuously gassed with 95%
O2-5% CO2, pH 7.4. In another series of experiments, islets
were perifused with Ca2+-free KBR containing 11.1 mM
glucose plus 250 mMdiazoxide and 10 mMEGTAwithout or
with 100 mMCch, as indicated in the legends to Figures 1-6.
A ratio image was acquired every 3 s with a Cool One
camera (Photon Technology International, USA) using a
dual filter wheel equipped with 340, 380, and 10 nm band-
pass filters, and a range of neutral density filters (Photon
Technology International). Data were acquired by using the
ImageMaster version 5.0 (Photon Technology International).
Pancreas morphometry and immunohistochemistry
For morphometric analysis, pancreases from all groups
of rats were removed, weighed, and fixed for 24 h in Bouin’s
solution, before embedding in paraffin. From each pancreas,
five consecutive 7-mmserial sections were selected; a space
of 140 mm in thickness was then retained, after five more
consecutive sections were obtained. Three sections were
randomly selected for insulin and one section for glucagon
immunoperoxidase reaction. For immunohistochemistry,
paraffin was removed; the sections were rehydrated and
washed with 0.05 M Tris-saline buffer (TBS), pH 7.4, and
subsequently incubated with TBS containing 0.3% H2O2 for
30 min to endogenous peroxidase activity blockade. They
were then permeabilized for a further 1 h with 0.1% Tween
20 and 5% of fat-free milk in TBS. Afterwards, the sections
were incubated with a polyclonal guinea pig anti-insulin
(1:150; Dako North America, Inc., USA) or rabbit anti-
glucagon (1:50; Dako North America, Inc.) antibody at 46C
overnight and, after this period, incubated with rabbit
anti-guinea pig or goat anti-rabbit conjugated antibody with
horseradish peroxidase for 1 h and 30 min. The positive
insulin or glucagon cells were detected with diaminobenzi-
dine (DAB; Sigma-Aldrich Chemicals) solution (10% DAB
and 0.2% H2O2 in TBS). Finally, the sections were stained
with Ehrlich’s hematoxylin and mounted for microscopy. All
islets present in the sections were systematically captured
with a digital camera coupled to a microscope (Olympus
DP71; Olympus BX60; Olympus, Japan).
Islet, b-cell, and a-cell areas were measured using the
Image-Pro-Plus Media, Cybernetics Program (USA), and
at least 750 islets per group from three to four rats were
sampled. The percentages of total islet and b-cell areas were
calculated by dividing the sum of the islet and b-cell areas,
respectively, per pancreas area section and multiplying
by 100 (21,22). The percentages of small, medium, and
large islets were calculated as previously reported (21). The
islet and b-cell masses were calculated by multiplying the
pancreas weight by the percentage of the total islet and b-
cells areas, respectively (22,23). The b-cell number was
quantified by counting the number of cellular nuclei within
the insulin immunoreactive area, and then the results were
expressed as b-cell number per 1000 mm2 of b-cell area. The
b-cell size was measured using the same material used for
determination of b-cell area, and was calculated by dividing
Figure 1. Body weight (A) of CTL, Cvag, MSG and Mvag rats
recorded over 6 weeks (n=6). Means±SE of the total BW (B)
reported as the area under growth curve (AUC), food consumption
(C) and food efficiency (D). BW: body weight; CTL: control; Cvag:
CTL with subdiaphragmatic vagotomy; MSG: monosodium gluta-
mate; Mvag: MSG with subdiaphragmatic vagotomy. *MSG and
Mvag were significantly different from controls. Different letters
indicate statistically significant differences (two-way ANOVA fol-
lowed by Duncan’s post-test, P#0.05).
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b-cell area per b-cell number in the insulin immunoreactive
area (24).
Statistical analysis
Results are reported as means ± SE for the number
of determinations (n) indicated. The statistical analyses
were carried out using two-way analysis of variance
(ANOVA) followed by the Duncan’s post-test or Student’s
t-test (P#0.05) with the Statistica 7.0 software (StatSoft,
USA).
Results
General rat parameters
Figure 1A shows that BW progression in MSG-treated
rats was significantly lower at 4 weeks after sham surgery,
compared to CTL (P,0.003). The total BW, as judged by
the area under the growth curve (AUC), was lower in MSG
rats than in CTL rats (P,0.02; Figure 1B). In addition, the
amount of food consumed during the experimental period by
MSG rats was lower than that of CTL rats (P,0.005; Figure
1C). However, the conversion of this food into efficient BW
gain in MSG rats was similar to that seen in CTL rats (Figure
1D). Vagotomy did not modify BW between the groups,
whereas it significantly reduced the total food intake in the
Cvag and Mvag groups, compared to their respective
controls (P,0.02 and P,0.001, respectively; Figure 1C),
and altered feeding efficiency in Mvag in comparison with
MSG rats (P,0.03; Figure 1D).
At the end of the experimental period, MSG rats showed
a reduction of 14 and 8% in final BW and nasoanal length,
respectively, compared to CTL rats (P,0.006 and P,0.007,
respectively; Table 1). MSG treatment efficiently induced
obesity, since the Lee index was higher and retroperitoneal
and perigonadal fat pads were larger in MSG rats compared
to CTL rats (P,0.002, P,0.0005, and P,0.0001, respec-
tively; Table 1). Vagotomy did not alter nasoanal length or
Lee index, but was effective for decreasing BW and pre-
venting fat deposition in Mvag rats, compared to MSG rats,
with reductions of 25% and 26% in the retroperitoneal and
perigonadal fat stores, respectively (P,0.05, P,0.02, and
P,0.05; Table 1). In addition, the size of the retroperitoneal
fat pad was also reduced in Cvag rats, compared to CTL rats
(P,0.01; Table 1). To confirm bilateral subdiaphragmatic
vagotomy, we analyzed the ratio between stomach weight
and BW (14). Cvag rats and Mvag rats presented higher
stomach weight per BW ratios (0.86±0.05 and 0.69±
0.01% BW, respectively), compared to CTL rats (0.49±
Figure 2. A, Changes in blood glucose during the intraperitoneal glucose tolerance test (ipGTT) in 90-day-old CTL, Cvag, MSG and
Mvag rats. B, Total plasma glucose concentrations during the ipGTT, reported as the AUC. C, Insulinemia at 0 and 30 min of the
ipGTT. Insulin sensitivity measured by HOMA-IR (D) and KITT (E). CTL: control; Cvag: CTL with subdiaphragmatic vagotomy; MSG:
monosodium glutamate; Mvag: MSG with subdiaphragmatic vagotomy; AUC: area under the curve; HOMA-IR: homeostasis model
assessment index; KITT: glucose disappearance rate. Data are reported as means±SE obtained from 8 rats for each group.
*Significant difference between MSG and CTL. Different letters indicate statistically significant differences (two-way ANOVA followed
by Duncan’s post-test, P#0.05).
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0.01% BW; P,0.001) and MSG rats (0.38±0.08% BW;
P,0.001), respectively.
Glucose tolerance and insulin sensitivity
At the end of the experimental period, all rat groups
were submitted to an ipGTT. Before glucose administra-
tion, fasted MSG rats did not show any alteration in blood
glucose levels, whereas they presented higher plasma
insulin levels (P,0.05; Figure 2, A and C). After glucose
loading, glycemia reached maximal levels at 15 min in all
groups (Figure 2A). MSG rats presented higher glycemia
levels at 15 and 60 min of the test, compared with CTL rats
(P,0.006 and P=0.05; Figure 2A). Total glycemia during
the ipGTT in MSG rats was 50% higher than the CTL group
(P,0.006; Figure 2B). In addition, at 30 min, insulinemia
was four-fold higher in MSG rats than in CTL rats (P,0.0001;
Figure 2C). Vagotomy normalized glucose tolerance and
insulinemia, before and at 30 min after the glucose injection,
in Mvag rats (Figure 2, A-C). Glucose intolerance in the
MSG group was in accordance with an impaired insulin
peripheral action, since the HOMA-IR was 3.3-fold higher
in MSG rats than in CTL rats (P,0.0005; Figure 2D). In
addition, the MSG group presented a 37% reduction in KITT,
compared with CTL rats (P,0.005; Figure 2E). Vagotomy,
performed at 30 days of age, normalized HOMA-IR and KITT
values, indicating a significant preventative effect on insulin
resistance in adult MSG rats (Figure 2, D and E).
Serum biochemical parameters and lipid content in
the liver
Fasting glucose levels were similar in all groups (Table 2);
however, normoglycemia in MSG rats was maintained by
hyperinsulinemia, compared to CTL (P,0.001; Table 2).
Vagotomy efficiently reduced insulinemia in Mvag rats,
with a decrease of 33% in serum insulin, in comparisonwith
MSG rats (P,0.03; Table 2). The MSG group presented
hypertriglyceridemia and hypercholesterolemia (P,0.0001
and P,0.005). Serum TG levels were efficiently reduced
in Mvag rats compared to MSG rats (P,0.03; Table 2).
Furthermore, the TG content in the liver of the MSG rats
was 57% higher than in CTL rats (P,0.02; Table 2). Early
subdiaphragmatic vagotomy normalized the TG content in
the liver of adult Mvag rats (Table 2). No alteration was
observed in total fat and CHOL content in the liver.
Islet insulin secretory function and Ca2+ handling
Figure 3A shows glucose-induced insulin secretion in
islets isolated fromCTL, Cvag, MSG, andMvag rats. Insulin
release at basal glucose concentration was similar for all
groups. At stimulatory glucose concentrations, the insulin
release was significantly higher in MSG rat islets compared
to CTL rat islets (P,0.001 andP,0.01, for 11.1 and 16.7 mM
glucose, respectively; Figure 3A). This effect was not due to
modifications in Ca2+ influx (Figure 4), since the AUC and
amplitude of the intracellular Ca2+ concentration ([Ca2+]i) in
MSG rat islets were similar to those of CTL rat islets, when
islets were perifused with 16.7 mM glucose (Figure 4, E
and G), whereas the MSG group presented a higher fre-
quency of Ca2+ oscillations than CTL rat islets (P,0.0001;
Figure 4F). Vagotomy partially reduced insulin secretion
at 11.1 mM glucose in Mvag rats, but did not modify the
hormone’s secretion at 16.7 mM glucose, compared to
MSG rats (Figure 3A). This effect was associated with a
lower total [Ca2+]i, but a higher number of Ca2+ oscillations
in response to 16.7 mM glucose in Mvag rat islets (P,0.03
and P,0.0001, respectively; Figure 4, D-F).
When the islets were incubated in the presence of
11.1 mM glucose plus 100 mM Cch, an M3 receptor agonist
(6), MSG rat islets did not present an increase in insulin
release (Figure 3B). However, Cch induced a higher intra-
cellular Ca2+ mobilization in the MSG group, since the total
quantity and amplitude of [Ca2+]i were enhanced inMSG rat
islets compared with CTL (P,0.006 and P,0.02; Figure 5,
C, E, and F). Mvag rat islets efficiently enhanced insulin
release in response to Cch (Figure 3B), and this effect was
accompanied by a normal intracellular Ca2+ mobilization
compared with CTL rat islets (Figure 5, D-F). In addition,
islet insulin content was 61% higher in MSG rat islets than in
CTL rat islets (P,0.01; Figure 3C). Subdiaphragmatic vagal
Figure 3.Glucose (A) and carbachol (Cch)-induced insulin secretion
(B), and total insulin content (C) of islets from 90-day-old CTL, Cvag,
MSG and Mvag rats. Groups of 4 islets were incubated for 1 h with
increasing glucose (G) concentrations, as indicated in the legend or
in the presence of 11.1 mM glucose without or with 100 mM Cch.
CTL: control; Cvag: CTL with subdiaphragmatic vagotomy; MSG:
monosodium glutamate; Mvag: MSG with subdiaphragmatic vagot-
omy. Data are reported as means±SE obtained from 16 groups of
islets. Different letters indicate statistically significant differences
(two-way ANOVA followed by Duncan’s post-test, P#0.05).
*G11.1+Cch was different from G11.1 in the same group of islets
evaluated (Student’s t-test; P#0.05).
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Figure 4. Representative curves of glucose-induced cytoplasmic Ca2+ oscillations in islets isolated from 90-day-old CTL (A), Cvag (B),
MSG (C) and Mvag (D) rats. The area under the curve (AUC) (during G16.7 condition=5-20 min) (E), frequency of Ca2+ oscillations
(F) and amplitude (G) of the [Ca2+]i in response to 16.7 mM glucose. The experiments were performed in a perifusion system in a
medium that contained 2.8 or 16.7 mM glucose (G2.8 and G16.7, respectively). The amplitude was calculated by subtracting the
highest fluorescence ratio obtained at G16.7 from G2.8 fluorescence values immediately before changing the glucose concentration in
the perifusion. Data are the ratio of F340/F380 registered for each group. CTL: control; Cvag: CTL with subdiaphragmatic vagotomy;
MSG: monosodium glutamate; Mvag: MSG with subdiaphragmatic vagotomy. Data are reported as means±SE that were obtained
from 4-14 independent experiments. Different letters represent statistically significant differences (two-way ANOVA followed by
Duncan’s post-test, P#0.05).
Figure 5. Representative curves of carbachol
(Cch) (100 mM) induced internal Ca2+ mobiliza-
tion in islets isolated from 90-day-old CTL (A),
Cvag (B), MSG (C) and Mvag (D) rats. E, AUC
and F, amplitude of the [Ca2+]i in response to
Cch. The experiments were performed in a
perifusion system in a Ca2+-free medium con-
taining: 11.1 mM glucose (G11.1), 250 mM diaz-
oxide, and 10 mM EGTA. Data are the ratio of
F340/F380 registered for each group. CTL:
control; Cvag: CTL with subdiaphragmatic vagot-
omy; MSG: monosodium glutamate; Mvag: MSG
with subdiaphragmatic vagotomy. Data are
reported as means±SE obtained from 6-10
independent perifusion experiments. Different
letters indicate statistically significant differences
(two-way ANOVA followed by Duncan’s post-
test, P#0.05).
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denervation did not alter islet insulin storage in the Cvag and
Mvag groups (Figure 3C).
Pancreatic islet morphology and morphometry
Figure 6A shows histological pancreatic sections stained
for insulin or glucagon. The pancreatic islet architecture was
not altered between the groups. Table 3 shows that MSG
rats presented reductions of 34 and 49% in the ratio of
pancreas weight per BW and total pancreas area, respec-
tively, compared to CTL rats (P,0.0001 and P,0.03). After
2 months of subdiaphragmatic vagotomy denervation, Mvag
rats presented 1.3- and 1.9-fold increases in pancreas
weight and area, respectively, compared with MSG rats
(P,0.04 and P,0.03, respectively; Table 3). Histological
analyses showed that pancreatic islets from MSG rats
were smaller and had a reduction in b-cell area without
modification in the a-cell content, compared with islets from
CTL rats (P,0.0001; Table 3). Furthermore, the MSG group
presented an increase in the percentage of total islet and b-
cell areas per pancreas section analyzed (P,0.0001), with
no modification in the distribution of islets by size (Table 3).
However, no alterations in islet and b-cell mass were ob-
served (Figure 6, B and C), but an increased b-cell number/
1000 mm2 of b-cell area was present in the MSG rat pan-
creas, compared with CTL (P,0.04; Figure 6E). In addition,
b-cell size was lower in the MSG group than in the CTL
Figure 6. Representative images of pancreas sections stained for insulin or glucagon and hematoxylin (A). Islet mass (B), b-cell mass
(C), b-cell size (D) and b-cell number (E) in the pancreas of 90-day-old control (CTL), CTL with subdiaphragmatic vagotomy (Cvag),
monosodium glutamate (MSG) and MSG with subdiaphragmatic vagotomy (Mvag) rats. Data are reported as means±SE (n=4).
Different letters indicate statistically significant differences (two-way ANOVA followed by Duncan’s post-test, P#0.05).
Table 1. Final body weight (BW), nasoanal length, Lee Index, retroperitoneal and perigonadal fat pads of 90-day old CTL, Cvag, MSG
and Mvag rats.
CTL Cvag MSG Mvag
BW (g) 361 ± 11a 337 ± 11a,b 310 ± 11b,c 277 ± 11c
Nasoanal length (cm) 24 ± 0.7a 25 ± 0.4a 22 ± 0.2b 22 ± 0.3b
Lee Index 286 ± 5a 278 ± 4a 311 ± 1b 304 ± 6b
Retroperitoneal fat pads (% BW) 0.9 ± 0.1a 0.5 ± 0.1b 1.6 ± 0.1c 1.2 ± 0.1d
Perigonadal fat pads (% BW) 0.9 ± 0.1a 0.8 ± 0.04a 1.9 ± 0.2b 1.4 ± 0.1a
Data are reported as means±SE (n=6). CTL: control; Cvag: CTL with subdiaphragmatic vagotomy; MSG: monosodium glutamate;
Mvag: MSG with subdiaphragmatic vagotomy. Different letters indicate statistically significant differences (P#0.05, two-way ANOVA
followed by Duncan’s post-test).
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group (P,0.02; Figure 6D). Pancreases of theMvag rats did
not present any alterations in islet and b-cell areas, com-
pared with MSG rats (Table 3). In addition, the percentage of
islet and b-cell areas per pancreas section (Table 3), as
well as b-cell number/1000 mm2 of b-cell area and b-cell
size per islet, were similar in the pancreases of Mvag and
CTL rats (Figure 6, D and E). However, the Mvag group
presented a higher islet number per pancreatic section
evaluated, compared with the CTL group (P,0.03; Table
3). Vagotomy, performed at 30 days of age, also reduced
the islet and b-cell areas in the pancreases of 90-day-old
Cvag rats (P,0.005 and P,0.02), without altering other
islet morphometric parameters (Table 3 and Figure 6).
Discussion
In the present study, we hypothesized that the increased
glucose-induced insulin secretion and hyperinsulinemia in
MSG rats may be linked to morphofunctional alterations in
the endocrine pancreas due to vagus nerve hyperactivity,
since an ANS imbalance with enhanced PNS but decreased
SNS action has been previously reported in MSG-induced
obesity (10). Therefore, we performed a subdiaphragmatic
vagotomy in 30-day-old MSG rats and, after 2 months, adult
vagotomized MSG rats exhibited a normalization of some b-
cell morphofunctional alterations and insulinemia, together
with the prevention of obesity development and glucose
homeostasis disruption.
Islet perifusion experiments demonstrated that en-
hanced glucose-induced insulin secretion in the MSG group
was not accompanied by an alteration in total [Ca2+]i in
response to glucose (Figure 4, C and E). However, MSG rat
islets did not increase insulin secretion in response to the
potentiating agent, Cch (Figure 3B). Previously, we demon-
strated a downregulation in the M3/protein kinase C (PKC)
pathway in MSG rat islets (18). Here, we extend the data
about the M3/PKCmechanism in the MSG islets, showing a
higher Ca2+ mobilization from internal stores in response to
Cch (Figure 5). It is known that, in b-cells, Cch increases
[Ca2+]i in a biphasic manner. The first phase is induced by
Table 2. Fasting serum glucose, insulin, TG and total CHOL concentrations and total fat, TG and CHOL content in the liver of 90-day-
old CTL, Cvag, MSG and Mvag rats.
CTL Cvag MSG Mvag
Glucose (mg/dL) 61 ± 4 63 ± 3 69 ± 3 67 ± 4
Serum insulin (ng/mL) 0.33 ± 0.07a 0.36 ± 0.07a 0.79 ± 0.1b 0.53 ± 0.06a
Serum TG (mg/dL) 126 ± 5a 105 ± 11a 271 ± 13b 224 ± 26c
Serum total CHOL (mg/dL) 84 ± 4a 81 ± 4a 111 ± 10b 103 ± 3b
Fat liver content (mg/g liver) 66 ± 2 66 ± 2 77 ± 5 64 ± 7
TG liver content (mg/mg liver) 9.3 ± 0.1a 8.0 ± 0.1a 14.6 ± 2.2b 9.8 ± 1.5a
CHOL liver content (mg/mg liver) 2.5 ± 0.2 2.4 ± 0.2 3.2 ± 0.3 3.3 ± 0.6
Data are reported as means±SE (n=6-11). CTL: control; Cvag: CTL with subdiaphragmatic vagotomy; MSG: monosodium glutamate;
Mvag: MSG with subdiaphragmatic vagotomy; TG: triglycerides; CHOL: total cholesterol. Different letters indicate statistically
significant differences (P#0.05, two-way ANOVA followed by Duncan’s post-test).
Table 3. Morphometric analysis of the pancreas of 90-day-old CTL, Cvag, MSG and Mvag rats.
CTL Cvag MSG Mvag
Pancreas weight (% BW) 0.43 ± 0.02ab 0.47 ± 0.03b 0.28 ± 0.02c 0.36 ± 0.02a
Pancreas area (cm2) 2.56 ± 0.30a 3.16 ± 0.27a 1.36 ± 0.11b 2.63 ± 0.17a
Islet area (mm2) 19225 ± 1044a 15965 ± 828b 13554 ± 659c 14674 ± 646b,c
b-cell area (mm2) 13582 ± 790a 11579 ± 612b 9859 ± 476c 10660 ± 488b,c
a-cell area (mm2) 2039 ± 209 2091 ± 272 2102 ± 241 2249 ± 193
Total islet area (% pancreas area) 0.72 ± 0.09a 0.61 ± 0.06a 1.09 ± 0.09b 0.72 ± 0.04a
Total b-cell area (% pancreas area) 0.51 ± 0.07a 0.44 ± 0.05a 0.79 ± 0.05b 0.53 ± 0.03a
% small islets (0-5,000 mm2) 39.9 ± 1.9 44.9 ± 2.7 48.5 ± 2.6 45.0 ± 2.6
% medium islets (5,000-10,000 mm2) 19.0 ± 2.5 16.1 ± 1.2 16.0 ± 1.2 17.2 ± 1.4
% large islets (.10,000 mm2) 41.1 ± 2.6 39.0 ± 2.5 35.5 ± 2.2 37.8 ± 2.3
Islet number per section 91 ± 14a 118 ± 9a,b 107 ± 9a,b 127 ± 4b
Number of islets analyzed 832 814 1091 1145
Data are reported as means±SE. CTL: control; Cvag: CTL with subdiaphragmatic vagotomy; MSG: monosodium glutamate; Mvag:
MSG with subdiaphragmatic vagotomy. Different letters indicate statistically significant differences (P#0.05, two-way ANOVA followed
by Duncan’s post-test).
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IP3, and the second phase is due to the opening of Ca2+
channels located on the plasma membrane (25). The
increase in [Ca2+]i together with DAG activates PKC,
which enhances the efficiency of Ca2+ in insulin granule
exocytosis (2). We recently demonstrated a lower PKC
content in MSG islets (18). This evidence suggests that a
disruption in insulin granule exocytosis occurs in the MSG
group, possibly due to PKC, even though the internal Ca2+
flux in response to Cch was adaptively enhanced.
Vagotomy did not alter insulin secretion at 16.7 mM
glucose in Mvag rats (Figure 3A) compared to MSG rats.
However, a reduction in glucose-induced insulin secretion
in islets from MSG rats submitted to early subdia-
phragmatic vagotomy has been reported previously (16).
In contrast, we found that Cch effectively enhanced insulin
secretion in Mvag islets (Figure 3B) and provoked a normal
intracellular Ca2+ mobilization (Figure 5). Although further
investigations are needed to verify the discrepant results
in glucose-induced insulin secretion in the Mvag group,
our data indicate that early vagotomy may prevent down-
regulation in the M3/PKC pathway, which may improve
Mvag b-cell function after a glucose stimulus, because
the PLC pathway is also activated in the presence of this
molecule in b-cells (26).
Pancreatic morphometry demonstrated that, although
islet and b-cell mass did not differ betweenMSGandCTL rat
pancreases (Figure 6, B and C), theMSG group presented a
higher percentage of total islet and b-cell areas per pancreas
section (Table 3), a higher b-cell number/1000 mm2 of b-cell
area (Figure 6E), with reduced b-cell size (Figure 6D). These
islet modifications demonstrate that increased insulin se-
cretion, at stimulatory glucose concentrations (Figure 3A),
as well as hyperinsulinemia (Table 2 and Figure 2C), are
associated with greater numbers of pancreatic b-cells in
MSG islets. Several lines of experimental evidence suggest
that the vagus nerve controls cellular proliferation in different
tissues in ventromedial hypothalamic lesioned rats (4,7,27-
29). This increased proliferation was inhibited by bilateral
subdiaphragmatic vagotomy or by administration of the
cholinergic blocker, atropine (4,27).
The above studies demonstrated that the vagus nerve
is important for the acute control of cellular replication;
however, its chronic action has been poorly investigated.
Our results indicated that the PNS was chronically involved
in endocrine pancreas modification in obesity of MSG rats
because, after 2 months of subdiaphragmatic vagotomy,
Mvag rats exhibited normal values for pancreas weight and
area, percentage of total islet and b-cell areas (Table 3),
b-cell number per b-cell area, and b-cell size (Figure 6).
These data are in accordance with reports demonstrating
that early subdiaphragmatic vagotomy decreased b-cell
proliferation in ob/ob mice (5). This evidence supports the
hypothesis that vagus nerve hypertonia during the onset of
obesity and insulin resistance may program b-cell number in
the pancreas. In addition, we observed that PNSactivity was
an important determinant of the islet and b-cell composition
in normal rats, since adult Cvag rats presented a decrease in
islet and b-cell areas without any alteration in the mass
content of whole pancreas (Figure 6, B and C).
Our study, in addition to detecting morphofunctional
alterations in the pancreas of MSG rats, also replicated the
obesity parameters that have been previously reported for
MSG rats (13-15,17,30), since MSG rats presented lower
values for BW and nasoanal length and increased values for
Lee index and fat deposition, normoglycemia, hyperinsulin-
emia, dyslipidemia, glucose intolerance, and insulin resistance
(Tables 1 and 2; Figures 1 and 2). Vagotomy, performed at
30 days of age, prevented obesity and improved glucose
tolerance and insulin sensitivity in adult Mvag rats (Tables 1
and 2, Figures 1 and 2). We also observed a decrease in
retroperitoneal fat deposition in Cvag rats (Table 1).
Prevention of body fat accumulation and an improvement
in glucose tolerance have been reported in Mvag rats
(14,31). It is known that, in the postprandial state, the
activation of parasympathetic efferent nerves improves the
action of insulin in target tissues (32,33). However, in
obesity, PNS hyperactivity occurs, leading to an adaptive
enhanced acetylcholinesterase activity (15,34); and this
effect may contribute to decreased insulin action and
development of type 2 diabetes.
We also demonstrated that Mvag rats presented lower
serum TG levels and normal TG content in the liver. It has
been accepted that vagal afferent nerves play an important
role in energy homeostasis. There have been reports of
experimental evidence for the involvement of vagal afferent
neurons in the transmission of satiety signals from the
gut to the CNS (35). Daly et al. (36) reported that the
consumption of an unhealthy diet promotes obesity due to
a reduction of gut signals to the CNS, which culminates in
increased food intake and increased weight. However, the
obesity induced by neonatal treatment with MSG is not
linked to a disruption in dietary consumption, but to altered
hypothalamic actions that increase PNS activity and de-
crease the action of the SNS (10), contributing to hype-
rinsulinemia, obesity and insulin resistance development.
As such, the nucleus tractus solitari senses all vagal affer-
ents and contributes to regulate energy balance (35).
Furthermore, insulin was reported to enhance the basal
activity of duodenal vagal mechanoreceptors, increasing
afferent input to the CNS (37); this action in MSG hyper-
insulinemic obese rats may enhance PNS activity. In
addition, vagal efferent nerves to the liver are involved
in insulin-induced hepatic lipogenesis (38). As such, we
hypothesized that subdiaphragmatic vagotomy abolishes
vagal afferent input to the CNS and efferent input to the liver,
which may decrease TG production and, consequently, its
levels in the blood serum.
In conclusion, we demonstrated for the first time that
hyperinsulinemia and insulin hypersecretion in response
to glucose in MSG rats was associated with an increase in
b-cell number promoted by PNS action in pancreatic islets.
In contrast, the MSG group presented a diminished islet
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secretory function in the presence of the cholinergic
stimulus, which may predispose these rodents to the early
development of b-cell dysfunction. Subdiaphragmatic
vagotomy, performed at 30 days of age, prevented islet
morphofunctional and whole body nutrient metabolism
alterations in adult Mvag rats. It is possible that increased
PNS activity in the endocrine pancreas of MSG rats was
responsible for the hyperinsulinemia that enhances fat
storage, damages glucose homeostasis, and reduces the
action of insulin in MSG-induced obesity.
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